Study of Iron Accumulation Measured in MRI in Non-pathological Aging
FER-IRM
2 other identifiers
observational
190
1 country
1
Brief Summary
To study the correlation between the iron load in brain, measured in MRI, and the age of healthy subjects Secondary objectives are to study the correlations between the iron load in cortical brain regions and (i) the cognitive performances, (ii) markers of aging (MRI, EEG, OCT, biology),and (iii) demographical factors involved in iron load.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2020
CompletedFirst Posted
Study publicly available on registry
December 9, 2020
CompletedStudy Start
First participant enrolled
January 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
May 29, 2025
May 1, 2025
5.9 years
December 2, 2020
May 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation coefficient between iron load in MRI and age
baseline
Study Arms (1)
Healthy
Eligibility Criteria
Healthy subjects from 18 to 95 years old stratified by sex and age groups
You may qualify if:
- Men or women between 18 and 95 years old
- French speaker with capability to understand the instructions
- Health insurance
You may not qualify if:
- Pregnancy
- minor subject
- no informed consent agreement
- MRI contra-indications
- Neurological or psychiatric disorders
- MOCA \< 26
- Psychotropic drugs
- More than 3 MRI exams
- More than 1 neuropsychological assessment (same cognitive tests) in the last 12 months
- Unable to follow the entire protocol according to the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Roger Salengro, CHU Lille
Lille, 59037, France
Study Officials
- PRINCIPAL INVESTIGATOR
Grégory KUCHCINSKI, MD
University Hospital, Lille
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2020
First Posted
December 9, 2020
Study Start
January 30, 2023
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Last Updated
May 29, 2025
Record last verified: 2025-05